✦ LIBER ✦

Moderate Renal Function Impairment Does Not Affect Outcomes of Reduced-Intensity Conditioning with Fludarabine and Melphalan for Allogeneic Hematopoietic Stem Cell Transplantation

✍ Scribed by Jonas A. de Souza; Rima M. Saliba; Poliana Patah; Gabriela Rondon; Rachel Ribeiro; Leandro de Padua Silva; Muzaffar H. Qazilbash; Chitra Hosing; Uday Popat; Yvonne Efebera; Richard E. Champlin; Marcos de Lima

Book ID: 116281081
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 192 KB
Volume: 15
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2009.05.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced-intensity conditioning for allog

Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome

✍ Nakamura, R; Rodriguez, R; Palmer, J; Stein, A; Naing, A; Tsai, N; Chang, K; Slo 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 199 KB

Allogeneic Hematopoietic Stem Cell Trans

Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of High-Risk Acute Myelogenous Leukemia and Myelodysplastic Syndrome Using Reduced-Intensity Conditioning with Fludarabine and Melphalan

✍ Betul Oran; Sergio Giralt; Rima Saliba; Chitra Hosing; Uday Popat; Issa Khouri; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 387 KB

Favourable outcome for patients with mye

Favourable outcome for patients with myeloid disorders treated with fludarabine–melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies

✍ R. K. Malladi; A. J. Peniket; A. E. Norton; A. J. Campbell; G. P. Collins; J. Sa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Comparison between two fludarabine-based

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan

✍ Shimoni, A; Hardan, I; Shem-Tov, N; Rand, A; Herscovici, C; Yerushalmi, R; Nagle 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 162 KB

CD34+ Cell Dose and Full Donor Chimerism

CD34+ Cell Dose and Full Donor Chimerism at Day +100 Is Associated with Survival in Patients Who Received Reduced-Intensity Conditioning (RIC) With Fludarabine/Melphalan Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies

✍ S.G. Holtan; W.J. Hogan; M.A. Elliott; D.A. Gastineau; T.G. Call; S.A. Ansell; D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB